Morgan Stanley Intercure Ltd. Transaction History
Morgan Stanley
- $1.59 Trillion
- Q3 2025
A detailed history of Morgan Stanley transactions in Intercure Ltd. stock. As of the latest transaction made, Morgan Stanley holds 4,027 shares of INCR stock, worth $5,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,027
Previous 4,177
3.59%
Holding current value
$5,396
Previous $6,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding INCR
# of Institutions
24Shares Held
2.92MCall Options Held
0Put Options Held
0-
Goldman Sachs Group Inc New York, NY1.26MShares$1.69 Million0.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ811KShares$1.09 Million0.06% of portfolio
-
Jane Street Group, LLC New York, NY214KShares$287,0990.0% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6213KShares$284,7500.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD109KShares$145,9040.03% of portfolio
About Intercure Ltd.
- Ticker INCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,133,900
- Market Cap $60.5M
- Description
- InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...